1. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.
- Author
-
Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, Tsuji S, Donehower LA, Slagle BL, Nakamura H, Yamamoto S, Shinbrot E, Hama N, Lehmkuhl M, Hosoda F, Arai Y, Walker K, Dahdouli M, Gotoh K, Nagae G, Gingras MC, Muzny DM, Ojima H, Shimada K, Midorikawa Y, Goss JA, Cotton R, Hayashi A, Shibahara J, Ishikawa S, Guiteau J, Tanaka M, Urushidate T, Ohashi S, Okada N, Doddapaneni H, Wang M, Zhu Y, Dinh H, Okusaka T, Kokudo N, Kosuge T, Takayama T, Fukayama M, Gibbs RA, Wheeler DA, Aburatani H, and Shibata T
- Subjects
- Algorithms, Asian People, Carcinoma, Hepatocellular epidemiology, CpG Islands, DNA Mutational Analysis, Exome, Gene Expression Regulation, Neoplastic, Genome, Viral, Hepacivirus genetics, Hepatitis B virus genetics, Humans, Japan, Liver Neoplasms epidemiology, Models, Statistical, Principal Component Analysis, TOR Serine-Threonine Kinases genetics, Telomerase genetics, United States, White People, Carcinoma, Hepatocellular ethnology, Carcinoma, Hepatocellular genetics, Genome, Human, Liver Neoplasms ethnology, Liver Neoplasms genetics, Mutation
- Abstract
Diverse epidemiological factors are associated with hepatocellular carcinoma (HCC) prevalence in different populations. However, the global landscape of the genetic changes in HCC genomes underpinning different epidemiological and ancestral backgrounds still remains uncharted. Here a collection of data from 503 liver cancer genomes from different populations uncovered 30 candidate driver genes and 11 core pathway modules. Furthermore, a collaboration of two large-scale cancer genome projects comparatively analyzed the trans-ancestry substitution signatures in 608 liver cancer cases and identified unique mutational signatures that predominantly contribute to Asian cases. This work elucidates previously unexplored ancestry-associated mutational processes in HCC development. A combination of hotspot TERT promoter mutation, TERT focal amplification and viral genome integration occurs in more than 68% of cases, implicating TERT as a central and ancestry-independent node of hepatocarcinogenesis. Newly identified alterations in genes encoding metabolic enzymes, chromatin remodelers and a high proportion of mTOR pathway activations offer potential therapeutic and diagnostic opportunities.
- Published
- 2014
- Full Text
- View/download PDF